Kataria, B. C. (2017). Lorcaserin: a selective serotonin receptor (5-HT2C) agonist for the treatment of obesity. International Journal of Basic & Clinical Pharmacology, 1(1), 45–47. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1398